Antimutagenic activity of new analogues of fluphenazine.
Fluphenazine (FPh) exhibited antimutagenic activity in lymphocyte cultures, markedly decreasing genotoxic effects of standard mutagenic agents present in cell cultures. However, the strong pharmacological activity of this neuroleptic drug, together with its serious side effects on the central nervous system, limits its use as an antimutagenic compound. In this paper we describe a route of chemical synthesis of FPh analogues that are more hydrophilic than the model compound, thus probably penetrate more weakly through the blood-brain barrier. These new analogues were tested for their antimutagenic and pro-apoptotic activities in human lymphocyte cultures, genotoxically damaged in vitro with benzo[a]pyrene [40 microM, 30 min] and subsequently cultured for 48 h in the presence of the tested compounds. The fluphenazine analogues enhanced apoptosis in genotoxically damaged lymphocytes more strongly than the model compound did. The increase of apoptotic cell frequency was the highest with compound 4a [2-(trifluoromethyl)-10-[3-(diethanolamino)-2-hydroxypropyl] phenothiazine]--a 35% higher effect than that of fluphenazine. The cytotoxicity of derivative 4a was the lowest among the tested compounds; it was 60% lower than that of fluphenazine. The antimutagenic effect of 4a was about 10% stronger than that of fluphenazine. Compound 4a also had the highest hydrophilicity of the new FPh analogues. Compound 4a was chosen for further study as a potentially usable antimutagen that would only weakly penetrate the central nervous system.
Gasiorowski
Kazimierz
K
Department of Basic Medical Sciences, Wrocław Medical University, Wrocław, Poland. kaz@basmed.am.wroc.pl
Malinka
Wiesław
W
Swiatek
Piotr
P
Jaszczyszyn
Agata
A
D000328:Adult; D016587:Antimutagenic Agents / Q000737:chemistry / Q000494:pharmacology*; D017209:Apoptosis / Q000502:physiology*; D001580:Benzopyrenes / Q000633:toxicity; D002478:Cells, Cultured; D005476:Fluphenazine / Q000032:analysis / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D008214:Lymphocytes / Q000166:cytology / Q000187:drug effects*; D008297:Male
D016587:Antimutagenic Agents; D001580:Benzopyrenes; D005476:Fluphenazine